REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers
- PMID: 12870567
- DOI: 10.1177/0269881103017002008
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers
Abstract
The potential use of rapid eye movement (REM) sleep effects as a biomarker for the therapeutic effects of antidepressants in healthy volunteers is reviewed. A literature search was performed to select studies investigating the effects of antidepressants on REM sleep. To assess the specificity of REM sleep effects as a biomarker, the effects of other central nervous system drugs on REM sleep were also investigated. A significant REM sleep reduction was shown for 16 of 21 investigated antidepressants after single-dose (mean reduction 34.1%) and for 11/13 drugs after multiple-dose administration (mean reduction 29.2%). The median increase in REM latency was approximatety 60% after single- or multiple-dose administration. REM sleep effects were linearly normalized to therapeutic doses, by dividing the REM sleep effect by the investigated dose and multiplying by the therapeutic dose. Normalized REM sleep effects were highly variable (range -27.0% to 81.8% for REM sleep; range -17.0% to 266.3% for REM latency) and demonstrated no relationship with relevant pharmacological properties of the investigated drugs. No quantifiable dose-response relationship could be constructed after single and multiple dose administration. REM sleep effects were not specific for antidepressants. Benzodiazepines, for example, caused an average dose normalized REM sleep reduction of 8.7% and a median 8.6% increase of REM latency. This review demonstrates that although REM sleep effects occur with most of the antidepressants, it is by itself of limited value as a biomarker for antidepressant action. The specificity for antidepressants is limited, and it does not show a quantitative dose-response relationship to antidepressant agents. This is at least partly due to the complex relationships between drug pharmacokinetics and the variable time course of REM and other sleep stages throughout the night. Models that take these complex relationships into account may provide more comprehensive and quantifiable results.
Similar articles
-
Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.Neuropsychobiology. 2005;51(3):134-47. doi: 10.1159/000085206. Epub 2005 Apr 18. Neuropsychobiology. 2005. PMID: 15838185 Clinical Trial.
-
REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials.Pharmacopsychiatry. 1990 Nov;23(6):253-8. doi: 10.1055/s-2007-1014515. Pharmacopsychiatry. 1990. PMID: 2284326
-
Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.Eur J Pharmacol. 2005 Oct 17;522(1-3):63-71. doi: 10.1016/j.ejphar.2005.08.050. Epub 2005 Oct 11. Eur J Pharmacol. 2005. PMID: 16223479
-
Antidepressants and sleep: a qualitative review of the literature.Drugs. 2005;65(7):927-47. doi: 10.2165/00003495-200565070-00003. Drugs. 2005. PMID: 15892588 Review.
-
[Biological models of depression: effect of antidepressants on sleep].Encephale. 1995 Dec;21 Spec No 7:35-40. Encephale. 1995. PMID: 8929677 Review. French.
Cited by
-
Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.J Psychopharmacol. 2015 Oct;29(10):1092-105. doi: 10.1177/0269881115592347. Epub 2015 Jul 14. J Psychopharmacol. 2015. PMID: 26174134 Free PMC article.
-
Mirtazapine induced nightmares in an adult male.Br J Clin Pharmacol. 2009 Jan;67(1):135-6. doi: 10.1111/j.1365-2125.2008.03305.x. Epub 2008 Nov 5. Br J Clin Pharmacol. 2009. PMID: 19006548 Free PMC article. No abstract available.
-
Pharmacokinetic and pharmacodynamic data to be derived from early-phase drug development: designing informative human pharmacology studies.Clin Pharmacokinet. 2008;47(6):373-81. doi: 10.2165/00003088-200847060-00002. Clin Pharmacokinet. 2008. PMID: 18479172 Review.
-
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.Br J Pharmacol. 2014 Sep;171(18):4255-72. doi: 10.1111/bph.12782. Br J Pharmacol. 2014. PMID: 24846338 Free PMC article.
-
Mirtazapine-induced nightmares.Prim Care Companion J Clin Psychiatry. 2006;8(5):311. doi: 10.4088/pcc.v08n0510b. Prim Care Companion J Clin Psychiatry. 2006. PMID: 17245439 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical